Clinical Trial Update: Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial assessing whether synbiotics can prevent febrile neutropenia in children with cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Febrile Neutropenia
• Infection in An Immunocompromised Host
• Neutropenia

Drugs mentioned

• Synbiotics

Snippet

Sponsor: S&D Pharma SK s.r.o. | Conditions: Febrile Neutropenia, Neutropenia | Phase 2 | Status: UNKNOWN